Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A real-world study of alemtuzumab in a cohort of Italian patients.
Russo CV, Saccà F, Frau J, Annovazzi P, Signoriello E, Bonavita S, Grasso R, Clerico M, Cordioli C, Laroni A, Capobianco M, Torri Clerici V, Sartori A, Cavalla P, Maniscalco GT, La Gioia S, Caleri F, Giugno A, Iodice R, Carotenuto A, Cocco E, Fenu G, Zaffaroni M, Baroncini D, Lus G, Gallo A, De Mercanti SF, Lapucci C, Di Francescantonio V, Brambilla L, Sormani MP, Signori A. Russo CV, et al. Among authors: lapucci c. Eur J Neurol. 2022 Jan;29(1):257-266. doi: 10.1111/ene.15121. Epub 2021 Oct 5. Eur J Neurol. 2022. PMID: 34558755 Free PMC article.
Quantitative assessment of finger motor impairment in multiple sclerosis.
Bonzano L, Sormani MP, Tacchino A, Abate L, Lapucci C, Mancardi GL, Uccelli A, Bove M. Bonzano L, et al. Among authors: lapucci c. PLoS One. 2013 May 31;8(5):e65225. doi: 10.1371/journal.pone.0065225. Print 2013. PLoS One. 2013. PMID: 23741485 Free PMC article.
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal.
Novi G, Ghezzi A, Pizzorno M, Lapucci C, Bandini F, Annovazzi P, Mancardi GL, Uccelli A. Novi G, et al. Among authors: lapucci c. Neurol Neuroimmunol Neuroinflamm. 2017 Jul 27;4(5):e377. doi: 10.1212/NXI.0000000000000377. eCollection 2017 Sep. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28804745 Free PMC article. No abstract available.
Different MRI patterns in MS worsening after stopping fingolimod.
Lapucci C, Baroncini D, Cellerino M, Boffa G, Callegari I, Pardini M, Novi G, Sormani MP, Mancardi GL, Ghezzi A, Zaffaroni M, Uccelli A, Inglese M, Roccatagliata L. Lapucci C, et al. Neurol Neuroimmunol Neuroinflamm. 2019 Apr 16;6(4):e566. doi: 10.1212/NXI.0000000000000566. eCollection 2019 Jul. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31086807 Free PMC article.
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort study.
Frau J, Saccà F, Signori A, Baroncini D, Fenu G, Annovazzi P, Capobianco M, Signoriello E, Laroni A, La Gioia S, Sartori A, Maniscalco GT, Bonavita S, Clerico M, Russo CV, Gallo A, Lapucci C, Carotenuto A, Sormani MP, Cocco E; i-MuST study group. Frau J, et al. Among authors: lapucci c. J Neurol. 2019 Oct;266(10):2440-2446. doi: 10.1007/s00415-019-09424-8. Epub 2019 Jun 17. J Neurol. 2019. PMID: 31209573
Effects of aging on finger movements in multiple sclerosis.
Signori A, Sormani MP, Lapucci C, Uccelli A, Bove M, Bonzano L. Signori A, et al. Among authors: lapucci c. Mult Scler Relat Disord. 2020 Jan;37:101449. doi: 10.1016/j.msard.2019.101449. Epub 2019 Oct 14. Mult Scler Relat Disord. 2020. PMID: 32173006
Tailoring B cell depletion therapy in MS according to memory B cell monitoring.
Novi G, Bovis F, Fabbri S, Tazza F, Gazzola P, Maietta I, Currò D, Bruschi N, Roccatagliata L, Boffa G, Lapucci C, Pesce G, Cellerino M, Solaro C, Laroni A, Capello E, Mancardi G, Sormani M, Inglese M, Uccelli A. Novi G, et al. Among authors: lapucci c. Neurol Neuroimmunol Neuroinflamm. 2020 Aug 4;7(5):e845. doi: 10.1212/NXI.0000000000000845. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32753406 Free PMC article.
82 results